Matrixyl 3000 vs Pentapeptide-18
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
Matrixyl 3000 is Sederma's follow-up to the original Matrixyl, a fixed pair of two fatty-acid-tagged peptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The idea is a one-two punch: one peptide tells skin to rebuild collagen, the other calms the low-grade inflammation that wears collagen down. It is a cosmetic ingredient aimed at firmness, fine lines and aging skin, with supportive but mostly company-generated evidence.
Also: Leuphasyl, Tyr-Ala-Gly-Phe-Leu
Pentapeptide-18 is Lipotec's Leuphasyl, a 'Botox-like' cosmetic peptide modeled on enkephalins, the body's own calming neuropeptides. It is mostly sold alongside Argireline, with the claim that the two relax expression lines better together. It is a cosmetic ingredient, and the evidence is small and mostly manufacturer-run.
Key Comparison Insights
- Both peptides belong to the Skin & Hair category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Matrixyl 3000 | Pentapeptide-18 |
|---|---|---|
| Category | Skin & Hair | Skin & Hair |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Both peptides are matrikines, short collagen-derived signals the skin treats as repair instructions. Palmitoyl tripeptide-1 nudges fibroblasts to produce more collagen, elastin and fibronectin, the scaffolding that keeps skin firm. Palmitoyl tetrapeptide-7 works on the other side of the equation by tamping down release of interleukin-6, an inflammatory messenger that climbs with age and quietly accelerates matrix breakdown, which in turn is thought to limit collagen glycation damage. As with the original Matrixyl, the palmitoyl tails are there to ferry these water-loving peptides through the skin barrier. The combined claim is build more, lose less. | Pentapeptide-18 is Tyr-Ala-Gly-Phe-Leu, a close copy of Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu) with one amino acid swapped. The theory is that it binds enkephalin receptors on nerve endings, which dampens nerve activity and lowers acetylcholine release at the junction with facial muscles. Argireline works at a different step (the SNARE complex inside the nerve ending), which is why the two get marketed as a combo. The same big caveat as Argireline applies: it is sold on a nerve-to-muscle mechanism, but nobody has shown in living skin that a topical cream delivers enough peptide to the muscle to do this. |
| Common Dosing | Limited community data available See research protocols | About 2-5% of the commercial solution in a finished product Once or twice daily |
| Administration | Topical (serums, creams) | Topical (serums, creams) |
| Typical Duration | Ongoing use for maintained effects | 28 days to 2 months in studies; ongoing use to maintain any effect |
| Best Time to Take | Morning or as directed | Morning and/or evening, on clean skin |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Matrixyl 3000 has a coherent, biologically reasonable mechanism, and in vitro studies do show its components stimulating fibroblast proliferation and synthesis of collagen types I, III, IV and VII, with the tetrapeptide reducing IL-6. The catch for a careful reader is that most of the supporting clinical work, including the commonly cited 12-week trials reporting reductions in wrinkles and skin laxity, originates from or was sponsored by the manufacturer rather than independent labs, and large published placebo-controlled trials specific to this exact complex are sparse. The strongest truly independent peptide evidence in this family is still the original Pal-KTTKS Matrixyl data. So Matrixyl 3000 is best described as a sensible, well-tolerated upgrade on paper with solid mechanistic and in vitro backing, but with human efficacy that rests heavily on industry sources rather than rigorous third-party trials. It targets collagen and inflammation, not muscle, so expectations should be texture and firmness, not Botox-like smoothing. | The most quoted numbers come from a Lipotec study: about 11% wrinkle reduction with 5% Leuphasyl alone over 28 days in a small panel, and about 25% with 5% Leuphasyl plus 5% Argireline. The company calls that synergy, but on its own figures the combination roughly equals the two effects added together, so 'synergistic' is a stretch. The one journal paper we found is Dragomirescu and colleagues (2014, Cosmetics, MDPI), which tested 0.5%, 1% and 2% emulsions around the eyebrows and eyes for efficacy and safety. Trade summaries say only the 2% cream gave a significant improvement after two months in about 20 volunteers; we could not read the full paper to confirm the numbers. A 2020 review of cosmetic peptides lists it among the neurotransmitter-inhibitor peptides and notes that much of the support comes from the manufacturer. Bottom line: safe enough as a skincare ingredient and plausible on paper, but expect subtle softening at most, not anything close to an injection. |
Frequently Asked Questions: Matrixyl 3000 vs Pentapeptide-18
What is the difference between Matrixyl 3000 and Pentapeptide-18?
Matrixyl 3000 is a skin & hair peptide that matrixyl 3000 is sederma's follow-up to the original matrixyl, a fixed pair of two fatty-acid-tagged peptides: palmitoyl tripeptide-1 (pal-ghk) and palmitoyl tetrapeptide-7 (pal-gqpr). the idea is a one-two punch: one peptide tells skin to rebuild collagen, the other calms the low-grade inflammation that wears collagen down. it is a cosmetic ingredient aimed at firmness, fine lines and aging skin, with supportive but mostly company-generated evidence. Pentapeptide-18 is a skin & hair peptide that pentapeptide-18 is lipotec's leuphasyl, a 'botox-like' cosmetic peptide modeled on enkephalins, the body's own calming neuropeptides. it is mostly sold alongside argireline, with the claim that the two relax expression lines better together. it is a cosmetic ingredient, and the evidence is small and mostly manufacturer-run. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Matrixyl 3000 or Pentapeptide-18?
Neither is universally "better" - the choice depends on your specific goals. Matrixyl 3000 is typically used for skin & hair purposes, while Pentapeptide-18 is used for skin & hair. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Matrixyl 3000 and Pentapeptide-18 be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Matrixyl 3000 and Pentapeptide-18 together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.